Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("ARGIRIS, Athanassios")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 46

  • Page / 2
Export

Selection :

  • and

Gefitinib as first-line, compassionate use therapy in patients with advanced non-small-cell lung cancerARGIRIS, Athanassios; MITTAL, Namrata.Lung cancer. 2004, Vol 43, Num 3, pp 317-322, issn 0169-5002, 6 p.Article

Prognostic factors and long-term survivorship in patients with recurrent or metastatic carcinoma of the head and neck : An analysis of two eastern cooperative oncology group randomized trialsARGIRIS, Athanassios; YI LI; FORASTIERE, Arlene et al.Cancer. 2004, Vol 101, Num 10, pp 2222-2229, issn 0008-543X, 8 p.Article

Progress in the therapy of small cell lung cancerSIMON, Miklos; ARGIRIS, Athanassios; MURREN, John R et al.Critical reviews in oncology/hematology. 2004, Vol 49, Num 2, pp 119-133, issn 1040-8428, 15 p.Article

Clinical Applications of Gene Therapy in Head and Neck CancerKARAMOUZIS, Michalis V; ARGIRIS, Athanassios; GRANDIS, Jennifer Rubin et al.Current gene therapy. 2007, Vol 7, Num 6, pp 446-457, issn 1566-5232, 12 p.Article

Therapies directed against epidermal growth factor receptor in aerodigestive carcinomasKARAMOUZIS, Michalis V; GRANDIS, Jennifer R; ARGIRIS, Athanassios et al.JAMA, the journal of the American Medical Association. 2007, Vol 298, Num 1, pp 70-82, issn 0098-7484, 13 p.Article

Targeting non-small cell lung cancer with epidermal growth factor tyrosine kinase inhibitors: where do we stand, where do we goPATEL, Jyoti D; PASCHE, Boris; ARGIRIS, Athanassios et al.Critical reviews in oncology/hematology. 2004, Vol 50, Num 3, pp 175-186, issn 1040-8428, 12 p.Article

Esthesioneuroblastoma: The northwestern University experienceARGIRIS, Athanassios; DUTRA, Jose; TSEKE, Paraskevi et al.The Laryngoscope. 2003, Vol 113, Num 1, pp 155-160, issn 0023-852X, 6 p.Article

PET scan assessment of chemotherapy response in metastatic paragangliomaARGIRIS, Athanassios; MELLOTT, Ann; SPIES, Stewart et al.American journal of clinical oncology. 2003, Vol 26, Num 6, pp 563-566, issn 0277-3732, 4 p.Article

Head and neck cancerARGIRIS, Athanassios; KARAMOUZIS, Michalis V; RABEN, David et al.Lancet (British edition). 2008, Vol 371, Num 9625, pp 1695-1709, issn 0140-6736, 15 p.Article

Pemetrexed in head and neck cancer: A systematic reviewARGIRIS, Athanassios; PENNELLA, Eduardo; KOUSTENIS, Andrew et al.Oral oncology (1997). 2013, Vol 49, Num 6, pp 492-501, issn 1368-8375, 10 p.Article

Outcome of elderly patients with recurrent or metastatic head and neck cancer treated with cisplatin-based chemotherapyARGIRIS, Athanassios; YI LI; MURPHY, Barbara A et al.Journal of clinical oncology. 2004, Vol 22, Num 2, pp 262-268, issn 0732-183X, 7 p.Article

Synergistic interactions between tamoxifen and trastuzumab (Herceptin)ARGIRIS, Athanassios; WANG, Chun-Xia; WHALEN, Steve G et al.Clinical cancer research. 2004, Vol 10, Num 4, pp 1409-1420, issn 1078-0432, 12 p.Article

Docetaxel and Irinotecan in Recurrent or Metastatic Head and Neck Cancer: A Phase 2 Trial of the Eastern Cooperative Oncology GroupARGIRIS, Athanassios; BUCHANAN, Ashley; BROCKSTEIN, Bruce et al.Cancer. 2009, Vol 115, Num 19, pp 4504-4513, issn 0008-543X, 10 p.Article

The Impact of Health Insurance Status on the Survival of Patients With Head and Neck CancerKWOK, Joseph; LANGEVIN, Scott M; ARGIRIS, Athanassios et al.Cancer. 2010, Vol 116, Num 2, pp 476-485, issn 0008-543X, 10 p.Article

Targeting growth factors and angiogenesis; using small molecules in malignancyWANEBO, Harold J; ARGIRIS, Athanassios; BERGSLAND, Emily et al.Cancer metastasis reviews. 2006, Vol 25, Num 2, pp 279-292, issn 0167-7659, 14 p.Conference Paper

Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group TrialARGIRIS, Athanassios; GHEBREMICHAEL, Musie; GILBERT, Jill et al.Journal of clinical oncology. 2013, Vol 31, Num 11, pp 1405-1414, issn 0732-183X, 10 p.Article

Planned post-chemoradiation neck dissection : Significance of radiation doseSTENSON, Kerstin M; DEZHENG HUO; BLAIR, Elizabeth et al.The Laryngoscope. 2006, Vol 116, Num 1, pp 33-36, issn 0023-852X, 4 p.Article

PROGNOSTIC FACTORS IN PATIENTS WITH HIGH-RISK LOCALLY ADVANCED SALIVARY GLAND CANCERS TREATED WITH SURGERY AND POSTOPERATIVE RADIOTHERAPYFEINSTEIN, Trevor M; LAI, Stephen Y; LENZNER, Diana et al.Head & neck. 2011, Vol 33, Num 3, pp 318-323, issn 1043-3074, 6 p.Article

Phase II Trial of Pemetrexed and Bevacizumab in Patients With Recurrent or Metastatic Head and Neck CancerARGIRIS, Athanassios; KARAMOUZIS, Michalis V; GOODING, William E et al.Journal of clinical oncology. 2011, Vol 29, Num 9, pp 1140-1145, issn 0732-183X, 6 p.Article

Phase II Study of Everolimus (RAD001) in Previously Treated Small Cell Lung CancerTARHINI, Ahmad; KOTSAKIS, Athanasios; GOODING, William et al.Clinical cancer research (Print). 2010, Vol 16, Num 23, pp 5900-5907, issn 1078-0432, 8 p.Article

A Phase 2 Trial of Bortezomib Followed by the Addition of Doxorubicin at Progression in Patients With Recurrent or Metastatic Adenoid Cystic Carcinoma of the Head and Neck: A Trial of the Eastern Cooperative Oncology Group (E1303)ARGIRIS, Athanassios; GHEBREMICHAEL, Musie; BURTNESS, Barbara et al.Cancer. 2011, Vol 117, Num 15, pp 3374-3382, issn 0008-543X, 9 p.Article

Phase II trial of 9-aminocamptothecin as a 72-h infusion in cutaneous T-cell lymphomaARGIRIS, Athanassios; HEALD, Peter; KUZEL, Timothy et al.Investigational new drugs. 2001, Vol 19, Num 4, pp 321-326, issn 0167-6997Article

Phase I Dendritic Cell p53 Peptide Vaccine for Head and Neck CancerSCHULER, Patrick J; HARASYMCZUK, Malgorzata; FERRIS, Robert L et al.Clinical cancer research (Print). 2014, Vol 20, Num 9, pp 2433-2444, issn 1078-0432, 12 p.Article

XPF Expression Correlates with Clinical Outcome in Squamous Cell Carcinoma of the Head and NeckVAEZI, Alec; XIAOZHE WANG; NIEDERNHOFER, Laura J et al.Clinical cancer research (Print). 2011, Vol 17, Num 16, pp 5513-5522, issn 1078-0432, 10 p.Article

Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancerARGIRIS, Athanassios; STENSON, Kerstin M; HARAF, Daniel J et al.Head & neck. 2004, Vol 26, Num 5, pp 447-455, issn 1043-3074, 9 p.Article

  • Page / 2